Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02564341 · ClinicalTrials.gov registry record · NA
Targeting Effective Analgesia in Clinics for HIV - Intervention
A NA study, sponsored by Boston Medical Center.
- Completed
- Registry status
- NA
- Development phase
- 41
- Enrollment target
NCT02564341: Completed NA study, sponsored by Boston Medical Center.
NCT02564341 is a NA study that has completed, run by Boston Medical Center. The registered enrollment target is 41 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (97% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02564341, a NA study, has completed, sponsored by Boston Medical Center.
- COMPLETED
- Registry status
- NA
- Development phase
- 41 participants
- Enrollment target
Study Summary
The TEACH randomized controlled trial will test the effectiveness of a collaborative care intervention directed towards physicians who provide care for HIV-infected persons to improve the quality of care for prescribing chronic opioid therapy (COT) for pain and reduce the misuse of prescription opioids among HIV-infected persons.
Interventions
- BEHAVIORAL Collaboration with an IT enabled nurse care manager
- BEHAVIORAL Education and academic detailing
- BEHAVIORAL Facilitated access to a specialist in addictions
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 41 participants |
| Start Date | 2015-09 |
| Est. Completion | 2018-11 |
| Phase | NA |
What the finished NCT02564341 record still lists
NCT02564341 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 41 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (97% lower).
The record links to 0 conditions, and to 3 interventions - of which Collaboration with an IT enabled nurse care manager is the first listed.
NCT02564341 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT02564341 about?
NCT02564341 is a clinical study titled "Targeting Effective Analgesia in Clinics for HIV - Intervention". The TEACH randomized controlled trial will test the effectiveness of a collaborative care intervention directed towards physicians who provide care for HIV-infected persons to improve the quality of care for prescribing chronic opioid therapy (COT) for pain and reduce the misuse of prescription opio...
What is the current status of trial NCT02564341?
This trial is currently completed. It is a NA study. The enrollment target is 41 participants. The study started on 2015-09. Estimated completion is 2018-11.
What interventions are being tested in trial NCT02564341?
The interventions under investigation include: Collaboration with an IT enabled nurse care manager (BEHAVIORAL), Education and academic detailing (BEHAVIORAL), Facilitated access to a specialist in addictions (BEHAVIORAL).
Who is sponsoring clinical trial NCT02564341?
This trial is sponsored by Boston Medical Center, which has 253 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT02564341's enrollment target sits among peer trials
41 1446th of 2000 higher than 554 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03449238 · 41 participants · Phase 1
Pembrolizumab And Stereotactic Radiosurgery (Srs) Of Selected Brain Metastases In Breast Cancer Patients
- NCT03900793 · 41 participants · Phase 1
Losartan + Sunitinib in Treatment of Osteosarcoma
- NCT04082520 · 41 participants · Phase 2
Lutathera for the Treatment of Inoperable, Progressive Meningioma After External Beam Radiation Therapy
- NCT04220190 · 41 participants · Phase 2
RAPA-501 Therapy for ALS
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia